The Facts
Costs from poor medication adherence are estimated to exceed $100 billion annually.
US House of Representatives Committee on Ways and Means
US Senate Committee on Health, Education, Labor, & Pensions
Essential Benefits
President Obama Sites V-BID as Method for Improving Medicare for a Second Time
V-BID Center Comments on two Affordable Care Act (ACA) Regulations
September 30--The V-BID Center submitted two letters to the Department of Health and Human Services commenting on draft regulations for the ACA. The first regulation implements recommendations from the Institute of Medicine regarding preventive services for women. The second regulation lays out some of the basic structures of the state health insurance Exchanges which are being rolled out in many states across the country.
> Read comments on preventive services for women
> Read comments on exchange governance
MedPAC Report to Congress, June 2011
The Medicare Payment Advisory Commission (MedPAC) report to Congress once again highlighted Value-Based Insurance Design as a promising policy for steering Medicare beneficiaries toward high-value care. MedPAC also highlighted V-BID in its 2010 report.
> Read Full Report
> Read V-BID Excerpt
National Prevention Strategy cites V-BID The report was called for under the Affordable Care Act and sets the agenda for prevention efforts across the government and the nation. It cites Section 2713 of the ACA and innovative health benefit designs as effective tools for delivering more preventive care to Americans.
V-BID in Connecticut State Employee Agreement
HHS REPORT TO CONGRESS:
On December 28, 2010, the Departments of Labor, Health and Human Services, and Treasury issued a Request for Information on V-BID and preventive care, further signifying its importance in health reform. The Center issued our response on February 28, 2011. > View Center's Response and Other RFI Resources
Comments on TRICARE preventive services
The V-BID Center submitted comments to Secretary of Defense Robert Gates on the Interim Final Rule for Elimination of Copayments for Authorized Preventive Services for Certain TRICARE Beneficiaries.
The Center supports the elimination of co-pays for selected evidence-based primary preventive services and calls for further elimination of co-pays for secondary prevention. The benefits of this value-based approach will be enhanced by committing to a sustained effort and educating beneficiaries on low-cost preventive services.
V-BID Center Comments on Rules Implementing Health Reform, September 17, 2010The V-BID Center submitted comments to the Department of Health and Human Services (HHS) concerning a new regulation on preventive care that includes the V-BID concept. The rule implements part of the new health reform law (the Patient Protection and Affordable Care Act).
The comments strongly endorse the design of the preventive care benefit outlined by HHS, which embodies the concept of V-BID by using clinical evidence to match populations with recommended medical care. The letter also expresses a hope that V-BID will be applied beyond primary prevention to secondary prevention, where it has been demonstrated to enhance health and contain costs.
> View Interim Final Rule (IFR)
MedPAC Report to Congress, June 2010Read the briefing and slides from MedPAC’s October 7, 2010 panel on identifying high- and low-value services.
The Seniors' Medication Copayment Reduction Act of 2009, the first V-BID demonstration bill, was introduced by Senator Debbie Stabenow and Senator Kay Bailey Hutchison. It would establish a demonstration program to test V-BID methodologies for Medicare beneficiaries with chronic conditions.
> View Bill
V-BID in Patient Protection and Affordable Care Act, April, 2010
Section 2713 (c) of the new law allows the Secretary of Health and Human Services to develop guidelines to permit health plans to use the concepts of value-based insurance design in providing coverage.
> Press Release
> Video
Costs from poor medication adherence are estimated to exceed $100 billion annually.
“The V-BID Program is not just a drug design, but we are putting our arms around the total health care spend and return.”
- Bill Bruning
President and CEO
MACHC